Cargando…
Superfast Magnetic Resonance Imaging-based Diagnostic Pathway for Prostate Cancer
We describe a <36-h superfast diagnostic pathway for men at risk of prostate cancer (PCa) that was initiated in our centre in March 2022. Patients are scheduled to undergo a repeat prostate-specific antigen blood test, magnetic resonance imaging, a urology consultation, and, if indicated, prostat...
Autores principales: | Paulino Pereira, Leonor Jane, Heetman, Joris G., van den Bergh, Roderick C.N., van Melick, Harm H.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615134/ https://www.ncbi.nlm.nih.gov/pubmed/36310760 http://dx.doi.org/10.1016/j.euros.2022.09.017 |
Ejemplares similares
-
Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?
por: Heetman, Joris G., et al.
Publicado: (2022) -
Magnetic Resonance Imaging–guided Active Surveillance of Prostate Cancer: Time to Say Goodbye to Protocol-based Biopsies
por: Giganti, Francesco, et al.
Publicado: (2022) -
TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate—Referee
por: van den Bergh, Roderick C.N., et al.
Publicado: (2021) -
Hormonal Intensification Should Start at the Low-risk Stage in Metastatic Prostate Cancer
por: Jazayeri, Seyed Behzad, et al.
Publicado: (2022) -
Is Artificial Intelligence Replacing Our Radiology Stars in Prostate Magnetic Resonance Imaging? The Stars Do Not Look Big, But They Can Look Brighter
por: Giganti, Francesco, et al.
Publicado: (2022)